Immunogenicity and Safety of Fluarix/ Influsplit SSW 2010/2011 or Pandemrix.

Trial Profile

Immunogenicity and Safety of Fluarix/ Influsplit SSW 2010/2011 or Pandemrix.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 24 Oct 2016

At a glance

  • Drugs Influenza A virus vaccine-H1N1 (Primary) ; Influenza virus vaccine (Primary)
  • Indications Influenza A virus H1N1 subtype; Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 17 Mar 2012 Actual end date (24 Feb 2011) added as reported by European Clinical Trials Database.
    • 31 Mar 2011 Status changed from not yet recruiting to discontinued.
    • 23 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top